FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:1066-1067 September 8, 2005 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Rosenhek, R. Related Article by Cowell, S. J. PubMed Citation

To the Editor: The Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE), reported by Cowell et al. (June 9 issue),¹ is a prospective study of the effect of lipid-lowering therapy in aortic stenosis. The result is important but does not convincingly refute the importance of lipids in the development of aortic stenosis because the study is susceptible to type II errors, owing to the small sample size and relatively short follow-up. In addition, it is surprising that only 5 of 155 patients in SALTIRE had a bicuspid aortic valve, which is the most common predisposing condition for . . . [Full Text of this Article]

This article has been cited by other articles:

• Greve, A. M., Wachtell, K. (2008). Review: Does lowering cholesterol have an impact on the progression of aortic stenosis?. Therapeutic Advances in Cardiovascular Disease 2: 277-286 [Abstract]